undamentalytics Newsletter
Sign in

Ceribell, Inc. revenue

Ceribell, Inc.'s revenue was $89.1m in fiscal 2025, up 36.1% on the year before. Over the last twelve months it was $102m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue456589102
Growth on the year before—+44.7%+36.1%—
Gross profit38577891
Gross margin84.4%86.7%87.9%88.9%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Products $67.3M 75.6% ▲ 34.5%
Subscription $21.7M 24.4% ▲ 41.4%

From Ceribell, Inc.'s 10-K filed February 24, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Ceribell, Inc. $102m 31.7% —
Delcath Systems, Inc. $95.4m 35.8% 230.8%
Xtant Medical Holdings, Inc. $110m -14.3% 17.3%
Sanara Medtech Inc. $110m 13.0% 22.6%
Owlet, Inc. $115m 28.2% 29.3%
Iradimed Corp $89.3m 11.0% 12.4%

Compare with peers

Head to head: CBLL vs DCTHCBLL vs XTNTCBLL vs SMTI

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Ceribell, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ceribell, Inc.